CDK4/6 inhibitor palbociclib enhances the effect of pyrotinib in HER2-positive breast cancer.
Zhang K, Hong R, Kaping L, Xu F, Xia W, Qin G, Zheng Q, Lu Q, Zhai Q, Shi Y, Yuan Z, Deng W, Chen M, Wang S.
Zhang K, et al. Among authors: lu q.
Cancer Lett. 2019 Apr 10;447:130-140. doi: 10.1016/j.canlet.2019.01.005. Epub 2019 Jan 21.
Cancer Lett. 2019.
PMID: 30677445